How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,964 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

221. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency

other methods ( e.g. , genotyping) to improve the positive predictive value of congenital adrenal hyperplasia screening. (1|⊕⊕○○) Technical remark: Laboratories utilizing liquid chromatography–tandem mass spectrometry should participate in an appropriate quality assurance program. Additionally, clinicians should realize that immunoassays lead to more false-positive results. Thus, if laboratory resources do not include liquid chromatography–tandem mass spectrometry, a cosyntropin stimulation test (...) with congenital adrenal hyperplasia, we recommend educating patients and their guardians and close contacts on adrenal crisis prevention and increasing the dose of glucocorticoid (but not mineralocorticoid) during intercurrent illness. (1|⊕⊕⊕○) 4.11 We recommend equipping every patient with congenital adrenal hyperplasia with a glucocorticoid injection kit for emergency use and providing education on parenteral self-administration (young adult and older) or lay administration (parent or guardian) of emergency

Full Text available with Trip Pro

2018 Pediatric Endocrine Society

222. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults

not all recommended tests and treatments, or both, might be available. Thus, the recommendations have certainly been interpreted in the context of available resources/treatment in the community, in which the patient is being seen. 3.4 Summary of methods used for guideline development The methods used have been described in more detail previously ( ). In short, the guideline used GRADE (Grading of Recommendations Assessment, Development and Evaluation) as a methodological base. The first step

Full Text available with Trip Pro

2018 European Society of Endocrinology

223. Prostate Cancer

prostate cancer: results from the REDUCE study. Prostate Cancer Prostatic Dis, 2013. 16: 254. 33. James, N.D., et al. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. N Engl J Med, 2017. 377: 338. 34. YuPeng, L., et al. Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies. Cancer Epidemiol Biomarkers Prev, 2015. 24: 1086. 35. Vidal, A.C., et al. Obesity increases the risk for high-grade prostate cancer: results from

2018 European Association of Urology

224. Management of Diabetic Foot

Stratification 8 3. REFERRAL 10 3.1 Foot Protection Team 10 3.2 Multidisciplinary Foot Care Team 10 4. PREVENTION 12 4.1 Patient Education 12 4.2 Metabolic Control 12 4.3 Preventive Foot Wear 13 4.4 Preventive Surgery 15 5. TREATMENT 17 5.1 Pharmacotherapy 17 5.2 Wound Management 19 5.3 Rehabilitation 24 6. MONITORING AND FOLLOW-UP 26 7. CHARCOT NEUROARTHROPATHY 27 8. IMPLEMENTING THE GUIDELINES 29 8.1 Facilitating and Limiting Factors 29 8.2 Potential Resource Implications 29Management of Diabetic Foot (...) (Second Edition) TABLE OF CONTENTS No. Title Page REFERENCES 31 Appendix 1. Example of Search Strategy 35 Appendix 2. Clinical Questions 35 Appendix 3. Semmes-Weinstein Monofilament Examination 38 Appendix 4. Diabetic Foot Assessment Form 39 Appendix 5. University of Texas Classification 41 Appendix 6. Patient Education Materials 42 Appendix 7. Footwear Advice 45 Appendix 8. Treatment of Neuropathic Pain 46 in Diabetic Foot Appendix 9. Types of Infections in Diabetic Foot 50 and Suggestions

2018 Ministry of Health, Malaysia

225. Adult Type 1 diabetes mellitus

process) Margaret Humphreys Clinical Specialist Diabetes Dietitian /National HSE Structured Patient Education Co-ordinator Cathy Breen Senior Dietitian Diabetes Mary Finn Senior Dietitian Diabetes Karen Townsend Clinical Nurse Specialist Diabetes Pauline O’Hanlon Clinical Nurse Specialist Diabetes Mary O’Scannail Clinical Nurse Specialist Diabetes Helen Twamley Clinical Nurse Specialist Diabetes Integrated Care Prof Brian McGuire Professor of Clinical Psychology Eilis Kearney Clinical Pharmacist 1 (...) summary 16 2.15 Summary budget impact analysis 17 2.16 Monitoring, evaluation and audit 18 2.17 Plan to update this National Clinical Guideline 18 Section 3: National Clinical Guideline recommendations 19 3.1 Diagnosis and early care planning 19 3.2 Support and individualised care 21 3.3 Education and information 22 3.4 Dietary management 23 3.5 Physical activity 25 3.6 Blood glucose management 25 3.7 Insulin therapy 28 3.8 Insulin delivery 30 3.9 Referral for islet or pancreas transplantation 31 3.10

2018 National Clinical Guidelines (Ireland)

226. Care of Adults with Neurofibromatosis Type 1

available elsewhere. 7 In childhood,NF1 Disclaimer: This practice resource is designed primarily as an educational resource for medical geneticists and other clinicians to help them provide quality medical services. Adherence to this practice resource is completely voluntary and does not necessarily assure a successful medical outcome. This practice resource should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed (...) ., for cholesterol, colonoscopy, for cervicalcancer)andvaccinationschedulesshouldbefollowed, regardless of NF1 diagnosis. Supplemental Resources lists useful websites and organizations. Although it is important to always consider NF1-associated etiologies for a new sign or symptom, common explanations will remain common (e.g., most hypertension is essential and not pheochromocytoma- related, most back pain will not be due to an MPNST, most headaches will not be tumor-associated). Repeated patient

2018 American College of Medical Genetics and Genomics

227. National Clinical Guideline on Adult type 1 diabetes mellitus

Registrar Endocrinologist at start of development process) Margaret Humphreys Clinical Specialist Diabetes Dietitian /National HSE Structured Patient Education Co-ordinator Cathy Breen Senior Dietitian Diabetes Mary Finn Senior Dietitian Diabetes Karen Townsend Clinical Nurse Specialist Diabetes Pauline O’Hanlon Clinical Nurse Specialist Diabetes Mary O’Scannail Clinical Nurse Specialist Diabetes Helen Twamley Clinical Nurse Specialist Diabetes Integrated Care Prof Brian McGuire Professor of Clinical (...) 2.12 Consultation summary 16 2.13 External review 16 2.14 Implementation summary 16 2.15 Summary budget impact analysis 17 2.16 Monitoring, evaluation and audit 18 2.17 Plan to update this National Clinical Guideline 18 Section 3: National Clinical Guideline recommendations 19 3.1 Diagnosis and early care planning 19 3.2 Support and individualised care 21 3.3 Education and information 22 3.4 Dietary management 23 3.5 Physical activity 25 3.6 Blood glucose management 25 3.7 Insulin therapy 28 3.8

2018 HIQA Guidelines

228. Breastfeeding - Promoting and Supporting the Initiation, Exclusivity, and Continuation of Breastfeeding in Newborns, Infants and Young Children

and Evaluation), and the rest of the RNAO Best Practice Guidelines Research and Development Team for their intense work in the production of this Guideline. Special thanks to the members of the RNAO expert panel for generously providing their time and expertise to deliver a rigorous and robust clinical resource. We couldn’t have done it without you! Successful uptake of best practice guidelines requires a concerted effort from educators, clinicians, employers, policy-makers, and researchers. The nursing (...) policies, procedures, protocols, and educational programs. 3. Note the recommendations that are applicable to your setting and that can be used to address your organization’s existing needs or gaps. 4. Develop a plan for implementing the recommendations, sustaining best practices, and evaluating outcomes. Implementation science G resources, including the Registered Nurses’ Association of Ontario (RNAO) Toolkit: Implementation of Best Practice Guidelines (2012), are available at www.RNAO.ca. In addition

2018 Registered Nurses' Association of Ontario

229. Management of Hypertension (5th Edition)

or acted as consultants to such firms (details are available upon request from the CPG Secretariat). SOURCES OF FUNDING The development of the CPG on Management of Hypertension (4th Edition) was supported via unrestricted educational grant from Merck Sharp & Dohme (Malaysia) Sdn. Bhd. The funding body was not involved in and has no influence on the development of the guidelines. iKEY MESSAGES Hypertension is defined as persistent elevation of systolic BP of 140mmHg or greater and/or diastolic BP of 90 (...) therapy including LDL-cholesterol lowering and better control of diabetes is also recommended. Recommendations • T reat blood pressure in hypertensives with peripheral arterial disease to 140/90 mmHg) are present in up to 80% of patients with acute stroke 209,210 while almost 25% of patient presents with markedly raised SBP values >180 mmHg. In a majority of patients, a decline in blood pressure without any specific medical treatment will occur within days or weeks. 211,212 A slightly higher systemic

2018 Ministry of Health, Malaysia

230. New Technologies for the Treatment of Peripheral Artery Disease

. A recent Canadian commentary noted that, in addition to educating clinicians to screen their patients for PAD and providing support to high-risk individuals, “a directory of resources available to help treat patients” would be useful. 53 Similarly, Alberta researchers who conducted a 2016 review of rehabilitation therapy for PAD noted the need for a survey of PAD rehabilitation programs across Canada to identify service gaps. 13 References Lovell M, Harris K, Forbes T, Twillman G, Abramson B, Criqui MH (...) is more common in older people (affecting an estimated 20% of those over the age of 65). 44 Risk factors for PAD include diabetes, smoking, high cholesterol, and high blood pressure. 10 Rates of diabetes and smoking are higher in low income communities. 45-47 People with diabetes are at much higher risk for PAD. 48 Diabetic foot ulcers are mainly caused by chronic nerve damage (peripheral neuropathy) and ischemia resulting from peripheral vascular disease. 49,50 About half of those with diabetic foot

2018 CADTH - Issues in Emerging Health Technologies

231. Prescribing patterns of dependence forming medicines

of interest Professor Sir John Strang is Head of Department for the Addictions academic activity of the IoPPN (Institute of Psychiatry, Psychology and Neuroscience), Kings College London, which includes conduct of diverse research studies and provision of educational activity in the Addictions. He is also Academic Lead of the Addictions CAG (Clinical Academic Group), within the KHP AHSC (King’s Health Partners Academic Health Sciences Centre). He also holds an honorary consultant appointment

2017 Public Health Research Consortium

232. Interventions to improve adherence to lipid-lowering medication. (PubMed)

/dL (95% CI 8.51 to 30.51; 3 studies; 333 participants; moderate-quality evidence). Over the long term (more than six months) total cholesterol decreased by a mean of 17.57 mg/dL (95% CI 14.95 to 20.19; 2 studies; 127 participants; high-quality evidence). Included studies did not report usable data for health outcome indications, adverse effects or costs/resource use, so we could not pool these outcomes. We assessed each included study for bias using methods described in the Cochrane Handbook (...) intervention (e.g. electronic reminders, pharmacist-led interventions, healthcare professional education of patients) versus usual care over the short term (six months or less), and were pooled in a meta-analysis. Participants in the intervention group had better adherence than those receiving usual care (odds ratio (OR) 1.93, 95% confidence interval (CI) 1.29 to 2.88; 7 studies; 11,204 participants; moderate-quality evidence). A separate analysis also showed improvements in long-term adherence rates (more

Full Text available with Trip Pro

2016 Cochrane

234. Diabetes Prevention Programs

Improvement IFG Impaired fasting glucose IGT Impaired glucose tolerance NDEP National Diabetes Education Program NDPP National Diabetes Prevention Program NHANES National Health and Nutrition Examination Survey NIH National Institutes of Health OGTT Oral glucose tolerance test P4P Pay for performance PICOTS Population, Intervention, Comparators, Outcomes, Timing, and Settings PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses PSA Public service advertisement QALY Quality-adjusted (...) Key Resources Examples In-person, individual coaching Lowest Highest 1 Humans, facilities DPP Trial In-person, group coaching Medium Medium 8-15 Humans, facilities Weight Watchers for Prediabetes Y Digital, human coaching (virtual interaction) High Medium 1-24 Humans, technology Omada® (Omada Health, Inc.) Virtual Lifestyle Management (VLM™, Canary Health, Inc.) Digital, fully-automated coaching (based on algorithms) Highest Lowest 1+ † Technology Alive-PD™ (Turnaround Health) *Average costs

2017 California Technology Assessment Forum

235. Nurses and pharmacists can prescribe as effectively as doctors

of nurse or pharmacist prescribing compared with doctor prescribing. Most studies were of chronic disease management in primary care settings in high income countries (25 from the US and six from the UK). Independent and supplementary prescribers in the NHS include not only the nurses and pharmacists, as covered in this review, but also other professions such as podiatrists, optometrists, and physiotherapists. At a time of high demand for NHS resources, with shortages of doctors in some specialties (...) for medical prescribing. Blood pressure: People prescribed drugs by nurses or pharmacists had lower systolic blood pressure than those prescribed drugs by doctors (-5.31mmHg, 95% confidence interval [CI] -6.46 to -4.16; in 12 trials, involving 4,229 participants). Cholesterol: People prescribed drugs by nurses or pharmacists had lower low density lipoprotein cholesterol than those prescribed drugs by doctors (-0.21 mmol/L, 95% CI -0.29 to -0.14; in seven trials, involving 1,469 participants). Blood sugar

2019 NIHR Dissemination Centre

236. Simple approaches to weight management of children and adolescents in primary care may not work

Simple approaches to weight management of children and adolescents in primary care may not work Simple approaches to weight management of children and adolescents in primary care may not work Discover Portal Discover Portal Simple approaches to weight management of children and adolescents in primary care may not work Published on 8 November 2016 doi: Brief education and motivational interventions delivered by primary care professionals in several short consultations had only a marginal effect (...) % of children aged two to 15 are obese and a further 14% are overweight. Children who are overweight or obese can experience bullying and low self-esteem which can lead to anxiety and depression and they are also much more likely to be obese as adults. Obesity can also cause high blood pressure, fatty deposits in arteries and raised cholesterol, which increase the risk of long term conditions, such as type 2 diabetes. Obesity can be hard to treat effectively. National and local strategies set out a range

2019 NIHR Dissemination Centre

237. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

Translational Sciences, Cincinnati Children’s Hospital Medical Center’s TS Foundation, as well as several advocacy groups (TS Society of the United States, the TS Global Alliance and the Turner Resource Network). The chairs of the consensus working group, Claus H Gravholt and Philippe F Backeljauw, were appointed by the ESE Clinical Committee and PES respectively. Other members of the working and writing group are Niels H Andersen (adult cardiologist), Gerard S Conway (adult endocrinologist), Olaf M Dekkers

Full Text available with Trip Pro

2016 European Society of Human Reproduction and Embryology

238. Exemplar clinical pathways for a stratified approach to cardiovascular disease

, and for stratification of patients along the clinical pathway. ? Building capability through clinical education by embedding the care pathways into specialist and non-specialist training, and developing capacity through additional, focused resources such as trained genetic nurses. ? Raising awareness with both clinicians and patients to facilitate entry onto the right clinical pathway as early as possible, and overcoming clinician and public negative perceptions which may impede patient management. ? Developing (...) should help to achieve this. Embedding FH pathways into clinical education Delegates highlighted the need to integrate FH pathways into clinical training, not only to support an understanding of the pathway but also to propagate a mindset where FH patients are treated as if they already have heart disease, as the high cholesterol from birth places patients at significant risk of coronary artery disease. The low pick up rate on cholesterol levels in primary care needs to be addressed. It was suggested

2016 Academy of Medical Sciences

239. Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared to Usual Care

. The ESP CC establishes standard operating procedures for the production of evidence synthesis reports; facilitates a national topic nomination, prioritization, and selection process; manages the research portfolio of each Center; facilitates editorial review processes; ensures methodological consistency and quality of products; produces “rapid response evidence briefs” at the request of VHA senior leadership; collaborates with HSR&D Center for Information Dissemination and Education Resources (CIDER (...) management aims to control symptoms and slow or stop disease progression. Chronic disease management is typically a multi-component intervention that includes medication therapy review, patient medication education, medication monitoring, immunizations, disease self-care and support, and/or prescribing authority. This topic was nominated by Heather Ourth, PharmD, VACO Pharmacy Benefits Management Program Manager, on behalf of the National Clinical Pharmacy Research Group, chartered by the VACO Clinical

2016 Veterans Affairs Evidence-based Synthesis Program Reports

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>